Cochrane Eyes and Vision US Satellite
CEV@US Personnel (past and present): Tianjing Li, Kay Dickersin, Roberta Scherer, Lori Rosman, Genie Han, Jimmy Le, Riaz Qureshi, Jiajun Wen, Kristina Lindsley, Sarah Money, Yuanxi Jia, and Kolade Fapohunda. Not pictured: Henry Jampel, Barbara Hawkins, Naira Khachatryan, Naresh Mandava, Alan Palestine, Ian Saldanha, Samuel Abariga, Renee Wilson, Sueko Ng, Lin Wang, Jianyu E, Nancy Fitton, and Claire Twose.
Cochrane is the only international organization that has the goal of synthesizing and keeping up to date the evidence for all of healthcare. Systematic reviews use explicit methods to identify, appraise, and synthesize available evidence for a clinical question. Cochrane Eyes and Vision (CEV) aims to prepare and promote access to systematic reviews of interventions used to prevent or treat eye conditions and/or visual impairment, and to help people adjust to visual impairment or blindness. For 17 years, CEV United States Satellite (CEV@US) has overseen production of systematic reviews contributing to eyes and vision comparative effectiveness research in the US in many ways. The purpose of comparative effectiveness research is to assist patients, clinicians, purchasers, and policy makers in making informed health decisions, and to contribute to evidence-based healthcare. Specifically, CEV@US aims to
- Build a comparative effectiveness research workforce within the field of vision science by educating and training health professionals on key topics;
- Partner with professional societies, academic medical centers, journals, and others to ensure that the knowledge underpinning clinical practice is reliable, available, and applied;
- Prepare systematic reviews addressing prioritized questions, publish the reviews, and regularly update them as new research emerges;
- Conduct foundational methodological research related to systematic reviews;
- Disseminate the results of our research.
Dr. Tianjing Li serves as the Director for CEV@US.
CEV@US Faculty, Staff and Students
Principal Investigator Tianjing Li, MD, MHS, PhD
Co-Investigators
- Naresh Mandava, MD
- Alan Palestine, MD
- Henry Jampel, MD, MHS
- Barbara S. Hawkins, MS, PhD, FSCT - Dr. Hawkins is Professor Emerita of Ophthalmology and Epidemiology. She is an epidemiologist and clinical trialist with more than 40 years of experience in eyes and vision research.
- Roberta Scherer, PhD, MA:
Production Manager
 | Renee F. Wilson, MS, is a Research Associate at the Johns Hopkins University School of Public Health. She has been the Managing Editor for the Cochrane Eye and Vision US Satellite (CEV@US) since 2018. Additionally, she works with the Johns
Hopkins University Evidence-based Practice Center (EPC) as a Senior Research Program Manager. Prior to this she was the Managing Editor for the Journal of General Internal medicine for five years.
|
Methodologist
 | Sueko Ng, MHS, is a methodologist with the Cochrane Eye and Vision US Satellite (CEV@US). Her role includes assisting the systematic review process, such as assessing the eligibility of relevant studies, critically appraising risk of bias,
extracting data, conducting qualitative and quantitative data synthesis, and preparing manuscripts for publication in The Cochrane Library. She received her Master of Health Science Degree from Johns Hopkins Bloomberg School of Public
Health. |
Information Specialists
Lori Rosman, MLS, AHIP
Claire Twose, MLIS
Consumer Coordinator
 | Genie Han, MS, is a Senior Research Project Coordinator with the Cochrane Eye and Vision US Satellite (CEV@US). She has been involved with CEV@US since 2012. Ms. Han also serves as the coordinator for Consumers United for Evidence-based
Healthcare (CUE), a coalition of consumer health advocacy organizations in the United States. |
Student Research Assistants
 | Riaz Qureshi, MSc, is a PhD Candidate at in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. Riaz's academic background includes a Bachelor of Science in public health and a Master of Science in epidemiology and biostatistics from the universities of Waterloo and Western Ontario, respectively. Riaz's research focuses on the methods used to investigate harms of interventions at different levels of evidence: from adverse events collected and reported in clinical trials to the synthesis of harms in systematic reviews.
|
 | Lin Wang, MHS, is a PhD candidate in the Department of Epidemiology at Johns Hopkins University Bloomberg School of Public Health. Lin worked for China Food and Drug Administration (FDA, now named National Medical Products Administration) for four years as a medical reviewer and principal staff member. Lin’s academic background includes a ScM in Epidemiology from Johns Hopkins University Bloomberg School of Public Health and a MD from Central South University Xiangya School of Medicine.
|
Statistical Editors
Barbara S. Hawkins, MS, PhD, FSCT
Editors
Esen Akpek, MD
Roy Chuck, MD, PhD
Diana Do, MD
David Friedman, MD, PhD, MPH
Sarah Mickow, DBO
Irene Kuo, MD
Quan Dong Nguyen, MD
Mitchell Scheiman, OD
Roberta Scherer, PhD, MA
Kirk Wilhelmus, MD, MPH, PhD